PharmaCyte Biotech, Inc.
CIK 1157075 · View on SEC EDGAR ↗
Activist
First SEC filing: Nov. 18, 2025 · Latest: Nov. 18, 2025
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 30, 2024 | PMCB | Series G Convertible Preferred Stock→ Common stock, par value $0.001 per share (3,854,626) | 3,854,626 | Direct |
| May 30, 2024 | PMCB | Warrants→ Common stock, par value $0.001 per share (3,854,626) | 3,854,626 | Direct |
| May 30, 2024 | PMCB | Warrants→ Common stock, par value $0.001 per share (3,854,626) | 3,854,626 | Direct |
| Nov. 28, 2023 | FEMY | 6.0% Senior Convertible Note due 2025→ Common stock, par value $0.001 per share (4,237,288) | 4,237,288 | Direct |
| Nov. 28, 2023 | FEMY | Series A Warrants→ Common stock, par value $0.001 per share (4,237,288) | 4,237,288 | Direct |
| Nov. 28, 2023 | FEMY | Series B Warrants→ Common stock, par value $0.001 per share (4,237,288) | 4,237,288 | Direct |